secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001437749-26-007567
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q4 revenue $48.5M, but operating loss of $10.6M on $12.2M impairment; GAAP EPS ($0.45)
--------------------------------------------------------------------------------

- Revenue $48.5M (+10.6% YoY); operating loss ($10.6M) vs profit $1.5M last year, driven by $12.2M intangible asset impairment.
- GAAP EPS ($0.45) includes ($0.57) impairment charge; adjusted EBITDA $5.7M (11.7% sales) vs $3.9M.
- Battery & Energy sales $45.9M (+15.1% YoY); Communications Systems $2.6M (-35.2%).
- Backlog $110.2M (+22% from Q3); management expects improved 2026 results.
- Rebranding consolidates sub-brands under Ultralife; expects $1.4M tax credit under 45X.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774926007567/0001437749-26-007567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774926007567/ulbi20260310_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-007567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer